monocyte targeting agents in combination with anti-PD-1 to treat patients with cancer with liver metastasis.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: